Fig. 3: PFS HER2 amplification-positive patients who received trastuzumab as the first-line treatment and were stratified based on the HER2 mutation status.
PFS progression-free survival, HER2 human epidermal growth factor receptor 2.
Fig. 3: PFS HER2 amplification-positive patients who received trastuzumab as the first-line treatment and were stratified based on the HER2 mutation status. | npj Breast Cancer
